Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

NCT00694122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Dawn Phenomenon

Interventions

DRUG: Lantus (glargine)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]